Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-08

Clinical Trial Update: Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating varenicline for individuals with schizophrenia or schizoaffective disorder who are also dependent on alcohol and nicotine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED